> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Meeting on Hereditary Angioedema Drug Development
- URL: https://www.fdaweb.com/public-meeting-on-hereditary-angioedema-drug-development/
- Published: 2017-07-20T12:00:00.000Z
- Updated: 2026-09-14T22:35:20.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139182

*Federal Register* notice: FDA has announced a 9/25 public meeting on “Patient-Focused Drug Development for Hereditary Angioedema.” The meeting is intended to allow the agency to obtain patients’ perspectives on the impact of hereditary angioedema (HAE) on daily life. FDA also is seeking patients’ views on treatment approaches for HAE. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-07-20/pdf/2017-15202.pdf?ref=fdaweb.com).